Stem cell infusion trial aims to slow kidney disease

NCT ID NCT06752577

First seen Jan 30, 2026 · Last updated May 15, 2026 · Updated 14 times

Summary

This study is testing whether a single or repeated infusion of donor stem cells is safe for people with chronic kidney disease, including those who have had a kidney transplant. The stem cells are taken from bone marrow and given through a vein or directly into the kidney arteries. Researchers will monitor 75 participants for side effects over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Mayo Clinic

    RECRUITING

    Jacksonville, Florida, 32224, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.